All Releases
 |
Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Dec 15, 2008
|
9.7 KB |
|
| |
SAN DIEGO, Dec 15, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that Ortho-McNeil-Janssen Pharmaceuticals, Inc. (Ortho-McNeil) initiated under their partnership a first-in-human Phase 1 clinical trial of APD597, a novel oral drug candidate discovered by Arena that targets the gluc...
|
|
Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
Dec 9, 2008
|
8.2 KB |
|
| |
SAN DIEGO, Dec 09, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced preliminary data from a Phase 2b clinical trial of APD125 measuring subjective endpoints in patients with primary insomnia. The initial data analysis indicates that APD125 did not meet the trial's primary or secondary...
|
|
Arena Pharmaceuticals to Host Research & Development Day on December 15, 2008
Dec 8, 2008
|
8.3 KB |
|
| |
SAN DIEGO, Dec 08, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) announced today that it will host a Research and Development
Day on Monday, December 15, 2008, beginning at approximately 12:00 p.m.
Eastern Time (9:00 a.m. Pacific Time). Speakers, including Jack Lief,
President and Chief Execut...
|
|
Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity
Dec 8, 2008
|
11.9 KB |
|
| |
SAN DIEGO, Dec 08, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) announced today publication of the Phase 2b clinical trial
results of lorcaserin, its novel drug candidate for the treatment of obesity,
in the December 4, 2008 issue of Obesity, the official peer reviewed journal
of The Obesity ...
|
|
Arena Pharmaceuticals to Present at the Piper Jaffray 20th Annual Health Care Conference
Nov 25, 2008
|
8.2 KB |
|
| |
SAN DIEGO, Nov 25, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) announced today that the company is scheduled to present at the
Piper Jaffray 20th Annual Health Care Conference on December 3, 2008 at 2:30
p.m. Eastern Time (11:30 a.m. Pacific Time) at the New York Palace Hotel in
New York Cit...
|
|
Arena Pharmaceuticals Announces Third Quarter 2008 Financial Results
Oct 30, 2008
|
15.0 KB |
|
| |
SAN DIEGO, Oct 30, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today reported financial results for the third quarter ended September 30, 2008.
Arena reported a net loss allocable to common stockholders in the third quarter of 2008 of $56.2 million, or $0.76 per share, and a net loss allocab...
|
|
Arena Pharmaceuticals to Present at the Oppenheimer 19th Annual Healthcare Conference
Oct 29, 2008
|
8.5 KB |
|
| |
SAN DIEGO, Oct 29, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that the company is scheduled to present at the Oppenheimer 19th Annual Healthcare Conference on November 4, 2008 at 8:40 a.m. Eastern Time (5:40 a.m. Pacific Time) at the Waldorf=Astoria Hotel in New York City. Rober...
|
|
Arena Pharmaceuticals to Report Third Quarter 2008 Financial Results and to Host Conference Call and Webcast on Thursday, October 30, 2008
Oct 23, 2008
|
8.7 KB |
|
| |
SAN DIEGO, Oct 23, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced it will report third quarter 2008 financial results after the NASDAQ Global Market closes on Thursday, October 30, 2008. That same afternoon, Jack Lief, Arena's President and Chief Executive Officer, and Robert E. Hof...
|
|
Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
Oct 22, 2008
|
8.5 KB |
|
| |
SAN DIEGO, Oct 22, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that the company is scheduled to present at the BIOCOM Investor Conference on October 28, 2008 at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) at the Hyatt Regency Hotel in La Jolla, California. Jack Lief, Arena's ...
|
|
Arena Pharmaceuticals to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference
Oct 7, 2008
|
8.6 KB |
|
| |
SAN DIEGO, Oct 07, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that the company is scheduled to present at the Natixis Bleichroeder Second Annual Hidden Gems Conference on October 13, 2008 at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time) at the Waldorf=Astoria Hotel in New York...
|
|
Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference
Sep 17, 2008
|
8.6 KB |
|
| |
SAN DIEGO, Sept 17, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that the company is scheduled to present at the UBS Global Life Sciences Conference on September 23, 2008 at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time) at the Grand Hyatt Hotel in New York City. Dominic P. Beha...
|
|
Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
Aug 28, 2008
|
8.5 KB |
|
| |
SAN DIEGO, Aug 28, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that the company is scheduled to present at the NewsMakers in the Biotech Industry Conference on September 4, 2008 at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time) at the Millennium Broadway Hotel in New York City....
|
|
Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights
Aug 5, 2008
|
16.3 KB |
|
| |
SAN DIEGO, Aug 05, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today reported financial results for the second quarter ended June 30, 2008.
Total revenues in the second quarter of 2008 were $2.6 million, compared to $4.8 million in the second quarter of 2007, and included $2.0 million in rev...
|
|
Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, August 5, 2008
Jul 29, 2008
|
7.3 KB |
|
| |
SAN DIEGO, July 29 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) today announced it will report second quarter 2008 financial
results after the NASDAQ Global Market closes on Tuesday, August 5, 2008. That
same afternoon, Jack Lief, Arena's President and Chief Executive Officer, and
Robert E. Hoffman, Arena's Vice Presiden...
|
|
Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
Jul 9, 2008
|
10.6 KB |
|
| |
SAN DIEGO, July 9 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) today announced positive results from a multiple-ascending dose
Phase 1b clinical trial of APD791 to evaluate the compound's safety,
pharmacokinetics and pharmacodynamics. APD791 is Arena's internally discovered
oral drug candidate intended for the tre...
|
|
Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
Jun 12, 2008
|
12.4 KB |
|
| |
SAN DIEGO, June 12 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) announced today that Dr. Thomas Roth of Henry Ford Hospital
presented data from Arena's positive Phase 2a clinical trial of APD125 for the
treatment of insomnia in an oral presentation at the SLEEP 2008 22nd Annual
Meeting of the Associated Profession...
|
|
Arena Pharmaceuticals to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference
Jun 6, 2008
|
7.8 KB |
|
| |
SAN DIEGO, June 6, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) announced today that the company is scheduled to present at the
Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology
Conference on June 11, 2008 at 1:00 p.m. Eastern Time (10:00 a.m. Pacific
Time) at the...
|
|
Arena Pharmaceuticals to Present at Citigroup's Global Healthcare Conference
May 19, 2008
|
7.7 KB |
|
| |
SAN DIEGO, May 19 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) announced today that the company is scheduled to present at
Citigroup's Global Healthcare Conference on May 22, 2008 at 8:30 a.m. Eastern
Time (5:30 a.m. Pacific Time) at the Hilton New York Hotel in New York City.
Robert E. Hoffman, Arena's Vice Presi...
|
|
Arena Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
May 8, 2008
|
7.7 KB |
|
| |
SAN DIEGO, May 8 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) announced today that the company is scheduled to present at the
Bank of America 2008 Healthcare Conference on May 14, 2008 at 5:20 p.m.
Pacific Time (8:20 p.m. Eastern Time) at the Four Seasons Hotel in Las Vegas,
Nevada. Dominic P. Behan, Ph.D., Arena'...
|
|
Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
May 7, 2008
|
8.2 KB |
|
| |
SAN DIEGO, May 7 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc.
(Nasdaq: ARNA) announced today that Taisho Pharmaceutical Co., Ltd. initiated
a Phase 1 clinical trial of a drug candidate under a GPCR-focused partnership
with Arena to develop compounds to treat psychiatric disorders. The drug
candidate is a novel oral compound inte...
|
|
|
